Venolife (Diosmin) [Phlebodia 600]

Instructions for Venolife Duo (Diosmin) [Phlebodia 600]

Release Form:

tab., film cover, 500 mg: 30 or 60 pcs.
tab., film cover, 1000 mg: 30 or 60 pcs.

Description:

Pills covered with film wrapped orange-pink color, oval, double-bulb; on the fracture - from light yellow to gray yellow, heterogeneous structure; marble is allowed.

1 tab
500 mg purified micronized flavonoid fraction
including diosmin 450 mg (90%)
flavonoids (in Hesperidine terms) 50 mg (10%)
Auxiliary substances: gelatin, magnesium staarat, cellulose microcrystalline, carboxymethyl starchmal sodium, talc.

Composition of the membrane: "Vivakout" (macrogol 6000, titanium dioxide, glycerol, magnesium Stearat, hypromellosis, iron coloring oxide red, iron coloring yellow oxide) , sodium lauryl sulfate.

10 pcs. - cell contour (3) packaging - cardboard packs.
10 pcs. - cell contour (6) packaging - cardboard packs.

ATX codes
C05CA53 Diosmin in combination with other drugs Venolife

Pharmacological groups / Group membership:

Ventonizing and venotrektor drug Venolife

Active substance:

purified micronized flavonoid fraction

Pharmacy Group [Phlebodia 600]:

Ventonizing and venotrektor

Pharmaceuticals [Phlebodia 600]:

The venotonizing agent also has angiotrektor properties. Reduces the tensile strength of veins and venous stagnation, reduces the permeability of capillaries and increases their resistance. The results of clinical trials confirm the pharmacological activity of preparations containing this active substance with regard to the indicators of venous hemodynamics.

Raises the venous tone: With the help of venous occlusionic plasmography, the time of venous emptying was reduced. Patients with signs of a marked microcirculation disorder after therapy with preparations containing this active substance have (statistically reliable compared to placebo) increased capillary resistance, estimated by the angiostereometry method.

Therapeutic effectiveness in the treatment of chronic veins of the lower limbs, as well as in the treatment of hemorrhoids has been shown.

Testimonials:

• The therapy of symptoms of venous-lymphatic insufficiency:
• pain
• lower limb cramps
• a sense of gravity and slack in the legs
• "fatigue" of the legs.
• Therapy of venous-lymphatic insufficiency:
• The edema of the lower limbs
• trophic changes in skin and subcutaneous fiber
• venous trophic ulcers.
• Symptomatic therapy of acute and chronic hemorrhoids.

Method of application, course and dosage:

To receive inside.
The dose depends on the indication to use.

Use in pregnancy and breastfeeding
To date, there have been no reports of unwanted effects in pregnant women.

It is not recommended to use during breastfeeding.

Side Action [Phlebodia 600]:

On the side of the nervous system: Rarely - dizziness, headache.
From the digestive system: often - diarrhea, dyspepsia, nausea, vomiting; not often - colite; Unspecified frequency - abdominal pain.
On the skin cover side: Rash, itching, nettles; unspecified frequency - isolated edema of the face, lips, eyelids; In exceptional cases - angionevrotic edema.
General reactions: rarely is there general malaise.

Contraindications to use Venolife:

Increased sensitivity to active substance.

Special Instructions:

In case of hemorrhoids, the use of this drug Venolife does not replace the specific treatment of other anal disorders.
If the symptoms do not disappear after the recommended course of therapy, a proktologist should be examined.
If there are vector circulation disorders, the maximum effect of treatment is ensured by combining therapy with a healthy (balanced) lifestyle: It is desirable to avoid long stay in the sun, long stay on the legs, and also recommended to reduce excess body weight. Walking and, in some cases, wearing special stockings improves blood circulation.

Nozology Venolife [Phlebodia 600]:

Variocotherapy extension of the lower limb veins with ulcer and inflammation
Venture Insufficiency (Chronic) (peripheral)
Lymphotec not classified in other headings
Hemorrhoids and perianal venous trombosis